Arthritis, Gouty
0.100
GeneticVariation
disease
GWASDB
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
23263486
2013
Arthritis, Gouty
0.100
GeneticVariation
disease
GWASCAT
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
31578528
2019
cervical cancer
0.010
Biomarker
disease
BEFREE
MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer .
27285984
2016
Cervix carcinoma
0.010
Biomarker
disease
BEFREE
MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer .
27285984
2016
Circadian Rhythms
0.100
GeneticVariation
phenotype
GWASCAT
Genome-Wide Association Study of Circadian Rhythmicity in 71,500 UK Biobank Participants and Polygenic Association with Mood Instability.
30120083
2018
Conventional (Clear Cell) Renal Cell Carcinoma
0.010
Biomarker
disease
BEFREE
Gene deletions involved in histone modification and chromatin remodeling affected individual subtypes (clear cell: SFMBT and SETD2; papillary type 2: BAZ1A) and the collective RCC group (KDM4C).
22483639
2012
Creatinine measurement, serum (procedure)
0.100
GeneticVariation
phenotype
GWASCAT
Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
29124443
2018
Glomerular Filtration Rate
0.100
GeneticVariation
phenotype
GWASCAT
Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
29124443
2018
Glomerular Filtration Rate
0.100
GeneticVariation
phenotype
GWASCAT
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
31152163
2019
×
CUI:
C0018099
Disease:
Gout
Gout
0.100
GeneticVariation
disease
GWASCAT
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
31578528
2019
×
CUI:
C0018099
Disease:
Gout
Gout
0.100
GeneticVariation
disease
GWASDB
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
23263486
2013
Hip circumference
0.100
GeneticVariation
phenotype
GWASCAT
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.
28552196
2017
Histiocytoma, Benign Fibrous
0.010
Biomarker
disease
BEFREE
The data support a neoplastic genesis of aneurysmal benign fibrous histiocytoma and indicate a pathogenetic role for LAMTOR1-PRKCD and NUMA1-SFMBT1 .
26432191
2015
Hypertensive disease
0.010
Biomarker
group
BEFREE
Among the 17 genes, IGF1, SLC4A4, WWOX, and SFMBT1 were not only identified by our gene-based association scan and gene expression analysis but were also replicated by a gene-based association analysis of the Hong Kong Hypertension Study.
22479346
2012
Hyperuricemia
0.100
GeneticVariation
disease
GWASCAT
Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
29124443
2018
Idiopathic normal pressure hydrocephalus (INPH)
0.010
GeneticVariation
disease
BEFREE
The present study demonstrates that a copy number loss within intron 2 of the SFMBT1 gene may be a genetic risk factor for shunt-responsive definite iNPH .
27861535
2016
Intelligence
0.100
GeneticVariation
phenotype
GWASCAT
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function.
29844566
2018
Intelligence
0.100
GeneticVariation
phenotype
GWASCAT
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
29326435
2019
Intelligence
0.100
GeneticVariation
phenotype
GWASCAT
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence.
29942086
2018
Kidney Failure, Chronic
0.100
GeneticVariation
disease
GWASCAT
Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
29124443
2018
Malignant neoplasm of brain
0.010
Biomarker
disease
BEFREE
Unlike other mammalian MBT domain proteins characterized to date that selectively recognize mono- and dimethylated lysines, SFMBT1 binds di- and trimethyl H3K4, both of which are enriched at active promoters.
23928305
2013
Malignant Neoplasms
0.010
PosttranslationalModification
group
BEFREE
These results highlight a critical role of SFMBT1 in epigenetic regulation, EMT, and cancer .
23928305
2013
Malignant tumor of cervix
0.010
Biomarker
disease
BEFREE
MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer .
27285984
2016
Primary malignant neoplasm
0.010
PosttranslationalModification
group
BEFREE
These results highlight a critical role of SFMBT1 in epigenetic regulation, EMT, and cancer .
23928305
2013
Renal Cell Carcinoma
0.010
Biomarker
disease
BEFREE
Gene deletions involved in histone modification and chromatin remodeling affected individual subtypes (clear cell: SFMBT and SETD2; papillary type 2: BAZ1A) and the collective RCC group (KDM4C).
22483639
2012